What is the official website of Agilent Pharma - Small Molecule and Biologics ?

The official website of Agilent Pharma - Small Molecule and Biologics is https://www.agilent.com/en/solutions/biopharma.

What is Agilent Pharma - Small Molecule and Biologics's cybersecurity risk score?

Agilent Pharma - Small Molecule and Biologics has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Agilent Pharma - Small Molecule and Biologics experienced?

According to Rankiteo, Agilent Pharma - Small Molecule and Biologics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Agilent Pharma - Small Molecule and Biologics been affected by any supply chain cyber incidents ?

According to Rankiteo, Agilent Pharma - Small Molecule and Biologics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Agilent Pharma - Small Molecule and Biologics have SOC 2 Type 1 certification ?

According to Rankiteo, Agilent Pharma - Small Molecule and Biologics is not certified under SOC 2 Type 1.

Does Agilent Pharma - Small Molecule and Biologics have SOC 2 Type 2 certification ?

According to Rankiteo, Agilent Pharma - Small Molecule and Biologics does not hold a SOC 2 Type 2 certification.

Does Agilent Pharma - Small Molecule and Biologics comply with GDPR ?

According to Rankiteo, Agilent Pharma - Small Molecule and Biologics is not listed as GDPR compliant.

Does Agilent Pharma - Small Molecule and Biologics have PCI DSS certification ?

According to Rankiteo, Agilent Pharma - Small Molecule and Biologics does not currently maintain PCI DSS compliance.

Does Agilent Pharma - Small Molecule and Biologics comply with HIPAA ?

According to Rankiteo, Agilent Pharma - Small Molecule and Biologics is not compliant with HIPAA regulations.

Does Agilent Pharma - Small Molecule and Biologics have ISO 27001 certification ?

According to Rankiteo,Agilent Pharma - Small Molecule and Biologics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Agilent Pharma - Small Molecule and Biologics operate in ?

Agilent Pharma - Small Molecule and Biologics operates primarily in the Biotechnology Research industry.

How many employees does Agilent Pharma - Small Molecule and Biologics have ?

Agilent Pharma - Small Molecule and Biologics employs approximately None employees people worldwide.

Does Agilent Pharma - Small Molecule and Biologics own any subsidiaries ?

Agilent Pharma - Small Molecule and Biologics presently has no subsidiaries across any sectors.

How many LinkedIn followers does Agilent Pharma - Small Molecule and Biologics have ?

Agilent Pharma - Small Molecule and Biologics's official LinkedIn profile has approximately 15,424 followers.

What is the NAICS classification code for Agilent Pharma - Small Molecule and Biologics ?

Agilent Pharma - Small Molecule and Biologics is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Agilent Pharma - Small Molecule and Biologics have a Crunchbase profile ?

No, Agilent Pharma - Small Molecule and Biologics does not have a profile on Crunchbase.

Does Agilent Pharma - Small Molecule and Biologics have a LinkedIn profile ?

Yes, Agilent Pharma - Small Molecule and Biologics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/agilent-biopharma.

How many cybersecurity incidents has Agilent Pharma - Small Molecule and Biologics experienced ?

As of August 7, 2026, Rankiteo reports that Agilent Pharma - Small Molecule and Biologics has not experienced any cybersecurity incidents.

How many peer or competitor companies does Agilent Pharma - Small Molecule and Biologics have ?

Agilent Pharma - Small Molecule and Biologics has an estimated 4,739 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

APSMB

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

Agilent Pharma - Small Molecule and Biologics Vendor Cyber Rating & Cyber Score

agilent.com

Add Your Compliance Badge

Discovering and developing both small molecule pharmaceuticals and biopharmaceuticals is a costly and difficult process. At every stage, from research to quality control and manufacturing, Agilent can help you make the right choices. Agilent understands your workflows and has a comprehensive portfolio of sample-to-data solutions that work seamlessly together to provide accurate and reproducible results. For Research Use Only. Not for use in diagnostic procedures.

APSMB A.I CyberSecurity Scoring

Scoring History

APSMB

Agilent Pharma - Small Molecule and Biologics CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

APSMB Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for APSMB

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Agilent Pharma - Small Molecule and Biologics in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Agilent Pharma - Small Molecule and Biologics in 2026.

Incident Types APSMB vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Agilent Pharma - Small Molecule and Biologics in 2026.

Incident History - APSMB (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Agilent Pharma - Small Molecule and Biologics Subsidiaries

APSMB

Biotechnology Research

Website: https://www.agilent.com/en/solutions/biopharma

Company Size: None employees

Agilent TechnologiesBiotechnology Research

Agilent Europe, Middle East & AfricaBiotechnologieforschung

Agilent América LatinaInvestigación biotecnológica

Agilent Diagnostics & Genomics SolutionsBiotechnology Research

Agilent Cell AnalysisBiotechnology Research

Loading…

Agilent Pharma - Small Molecule and Biologics Similar Companies

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Loading…

NEWS

Agilent Pharma - Small Molecule and Biologics CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-8325

SUMMARY

A maliciously crafted PDF file, when parsed through Autodesk Revit, can force an Out-of-Bounds Write vulnerability. A malicious actor may leverage this vulnerability to cause a crash, cause data corruption, or execute arbitrary code in the context of the current process.

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-7867

SUMMARY

A flaw was found in udisks2. A local attacker with an active console session can exploit insufficient authorization checking on the 'as-user' option in the org.freedesktop.UDisks2.Filesystem.Mount() D-Bus method. This allows the attacker to spoof the 'as-user' parameter, mounting filesystems on behalf of arbitrary users, including privileged accounts. This can lead to local privilege escalation through mount point injection and manipulation of the mount namespace visible to privileged users.

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-7406

SUMMARY

A maliciously crafted BMP file, when parsed through certain Autodesk products, can force a Untrusted Pointer Dereference vulnerability. A malicious actor can leverage this vulnerability to execute arbitrary code in the context of the current process.

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-7405

SUMMARY

A maliciously crafted TIF file, when parsed through certain Autodesk products during image import, can cause an Out-of-Bounds Read in the image handling library. A malicious actor can leverage this vulnerability to cause a denial of service

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.8

REFERENCES

CVE-2026-71555

SUMMARY

PILOS (Platform for Interactive Live-Online Seminars) is a frontend for BigBlueButton. From 2.1.0 until 4.14.1, PILOS does not send a Cross-Origin-Opener-Policy response header, so pages opened by PILOS via a link that opens a new browsing context (e.g., target="_blank") retain a window.opener reference back to the originating PILOS tab. A malicious destination page reached this way can use window.opener to navigate or manipulate the original PILOS tab, a technique known as reverse tabnabbing, potentially redirecting an authenticated user to a phishing page that mimics PILOS. This issue is fixed in version 4.14.1.

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 4.1)

cvss3

Base Score: 4.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:N/I:L/A:N

Impact Score

1.4

Exploitability

2.3

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…